The Operator's Guide to
Weight Loss Medications
What Are GLP-1 Medications and How Do They Work
Semaglutide vs. Tirzepatide: Head-to-Head
Both medications are effective, but there are meaningful differences that matter when selecting a protocol:
| Factor | Semaglutide (Wegovy) | Tirzepatide (Zepbound) |
|---|---|---|
| Mechanism | GLP-1 receptor agonist | Dual GLP-1/GIP agonist |
| Average Weight Loss | ~15% body weight (68 weeks) | ~20-22% body weight (72 weeks) |
| Dosing | Weekly injection or daily oral pill | Weekly injection |
| FDA Approval (Weight) | Wegovy (injectable + oral) | Zepbound |
| Common Side Effects | Nausea, diarrhea, constipation | Nausea, diarrhea, constipation |
| Oral Option | Yes (approved Dec 2025) | Not yet available |
| Cost (Cash Pay) | Starting at ~$149/mo (oral) | Starting at ~$299/mo |
The right choice depends on your metabolic profile, tolerance, goals, and what your bloodwork reveals. This is exactly why T1Rx starts every weight loss protocol with a comprehensive blood panel and physician evaluation.
ORAL VS. INJECTABLE:
WHAT CHANGED IN 2025
The approval of the Wegovy Pill in December 2025 was a significant shift. For the first time, men who prefer not to inject have a GLP-1 option that is specifically FDA-approved for weight management. The oral version requires daily dosing, must be taken on an empty stomach with minimal water, and requires a 30-minute fast afterward. Early prescribing data suggests that a higher proportion of men are opting for the oral version compared to injectables. The weekly injection, however, remains simpler in terms of compliance since you only have to think about it once. Your provider can help determine which format suits your routine and your discipline.
Who Qualifies for Weight Loss Medication
The Real Risk: Losing Muscle Along with Fat